Trial
NCT04334408
Safety and Efficacy of Fremanezumab for Migraine in Adult CADASIL
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Mayo Clinic
Collaborators
—
Condition
Cadasil
Intervention
Fremanezumab
Why stopped
Lack of funding to support the trial.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-02-28